ID: ALA4441492

Max Phase: Preclinical

Molecular Formula: C47H73N5O13S

Molecular Weight: 948.19

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@H]1O[C@@H](O[C@H]2CC[C@]3(/C=N/NC(=O)CCCCCCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@@H]54)[C@H]4C[C@@H](O)[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C47H73N5O13S/c1-26-39(57)40(58)41(59)42(64-26)65-28-13-16-45(31-21-34(53)44(2)29(27-20-37(56)63-23-27)15-18-47(44,62)30(31)14-17-46(45,61)22-28)25-49-52-36(55)12-6-4-3-5-9-19-48-35(54)11-8-7-10-33-38-32(24-66-33)50-43(60)51-38/h20,25-26,28-34,38-42,53,57-59,61-62H,3-19,21-24H2,1-2H3,(H,48,54)(H,52,55)(H2,50,51,60)/b49-25+/t26-,28+,29-,30-,31+,32+,33+,34-,38+,39+,40-,41-,42+,44+,45+,46+,47+/m1/s1

Standard InChI Key:  XJHUQDLXFFBVKZ-VTFKPSHESA-N

Associated Targets(non-human)

Streptavidin (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 948.19Molecular Weight (Monoisotopic): 947.4926AlogP: 1.81#Rotatable Bonds: 18
Polar Surface Area: 277.83Molecular Species: NEUTRALHBA: 15HBD: 10
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.85CX Basic pKa: 1.86CX LogP: 0.08CX LogD: 0.08
Aromatic Rings: 0Heavy Atoms: 66QED Weighted: 0.02Np Likeness Score: 1.58

References

1. Tian DM, Qiao J, Bao YZ, Liu J, Zhang XK, Sun XL, Zhang YW, Yao XS, Tang JS..  (2019)  Design and synthesis of biotinylated cardiac glycosides for probing Nur77 protein inducting pathway.,  29  (5): [PMID:30670347] [10.1016/j.bmcl.2019.01.015]

Source